References
- Benagiano G, Morini A, Primiero FM. 1992. Fibroids: overview of current and future treatment options. British Journal of Obstetrics and Gynaecology 99\(Suppl 7):18–22.
- Buttram VC Jr. and Reiter RC. 1981. Uterine leiomyomata: etiology, symptomatology, and management. Fertility and Sterility 36(4):433–445.
- Cantuaria GH, Angioli R, Frost L, Duncan R, Penalver MA. 1998. Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma. Ob-stetrics and Gynecology 92(1):109–112.
- Fletcher H, Frederick J, Hardie M, Simeon D. 1996. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstetrics and Gyne-cology 87(6):1014–1018.
- Healy DL, Vollenhoven BJ. 1992. The role of GnRH agonists in the treatment of uterine fibroids. British Journal of Obstetrics and Gynaecology 99(Suppl 7):23–26.
- Sauer MV, Agnew C, Worthen N, Gorrill MJ, Rodi IA, Bustillo MC, Buster JE. 1988. Reliability of ultrasound in predicting uterine leiomyoma volume. J Reproductive Medicine 33(7):612–614.
- Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT. 2000. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. American Journal of Obstetrics and Gynecology 183(6):1448–1455.